340B Accountability Act of 2023

Bill: 118-s-1133
Sponsor: full_name: Sen. Braun, Mike [R-IN]
Introduced: 2023-03-30
Policy area: Health
Latest action: action_date: 2023-03-30
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2023-03-30
action_desc: Introduced in Senate
text: <p><strong>340B Accountability Act of 202</strong><b>3</b></p> <p>This bill requires participants in the 340B drug pricing program to allow the Health Resources &amp; Services Administration (HRSA) to audit their records to determine how they use the net income from the discounted drug prices under the program. Participants also must retain records and reports as necessary for HRSA to perform the audits.</p>

tv_txt: II 118th CONGRESS 1st Session S. 1133 IN THE SENATE OF THE UNITED STATES March 30, 2023 Mr. Braun introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To amend the Public Health Service Act to clarify rules relating to drug discounts for covered entities.

1. Short title This Act may be cited as the 340B Accountability Act of 2023 . 2. Drug discounts and audits for covered entities Section 340B(a)(5)(C) of the Public Health Service Act ( 42 U.S.C. 256b(a)(5)(C) ) is amended— (1) by striking A covered entity shall permit and inserting the following: (i) Duplicate discounts and drug resale A covered entity shall permit ; and (2) by adding at the end the following: (i) Use of savings A covered entity shall permit the Secretary to audit, at the Secretary's expense, the records of the entity to determine how net income from purchases under this section are used by the covered entity. (ii) Records retention A covered entity shall retain such records and provide such records and reports as determined necessary by the Secretary for carrying out this subparagraph. .